Pemphigus and bullous pemphigoid

Lancet

Volumn 354, Issue 9179, 1999, Pages 667-672

  Nousari, Hossein C ^a   Anhalt, Grant J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTOANTIBODY; AZATHIOPRINE; CELL ADHESION MOLECULE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DESMOGLEIN; GOLD; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PENICILLAMINE; PREDNISONE; TETRACYCLINE;

ARTICLE; AUTOIMMUNE DISEASE; BLISTER; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CYTOPENIA; HLA SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUCOUS MEMBRANE PEMPHIGOID; PARANEOPLASTIC SYNDROME; PEMPHIGOID; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

EID: 0033592153     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03007-X     Document Type: Review

References (31)

1. Stanley J.R. Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med. 181:1995;1-4.
2. Nousari H.C., Anhalt G.J. Bullous diseases. Curr Opin Immunol. 7:1995;844-852.
3. Ahmed A.R., Yunis E.J., Khatri K.et al. Major histocompatibility complex haplotype studies in Askenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA. 87:1990;7658-7662.
4. Sinha A.A., Brautbar C., Szafer F.et al. A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. Science. 139:1988;10026-10029.
5. Anhalt G.J., Labib R.S., Vorhees J.J.et al. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 306:1982;1189-1196.
6. Amagai M., Klaus-Kovtum V., Stanley J.R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris. Cell. 67:1991;869-877.
7. Ishii K., Amagai M., Hall R.P.et al. Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus expressed recombinant proteins. J Immunol. 159:1997;2010-2017.
8. Amagai T., Hashimoto T., Shimizu N., Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest. 94:1994;59-67.
9. Anhalt G.J., Till G.O., Diaz L.A.et al. Defining the role of complement in experimental pemphigus in mice. J Immunol. 137:1986;2835-2840.
10. Anhalt G.J., Patel H.P., Labib R.S.et al. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. J Immunol. 136:1986;113-117.
11. Koch P.J., Mahoney M.G., Ishikawa H.et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol. 137:1997;1091-1102.
12. Ding X., Aoki V., Mascaro J.M.et al. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol. 109:1997;592-596.
13. Anhalt G.J. Bullous diseases. Rakel R.E. Conn's current therapy. 1995;766-772 WB Saunders, Philadelphia.
14. Nousari H.C., Sragovich A., Kimyai-Asadi A.et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol. 40:1999;265-268.
15. Mahoney M.G., Rothenberger K., Koch P.J., Amagai M., Stanley J.R. Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 103:1999;461-468.
16. Diaz L.A., Sampaio S.A.P., Rivitti E.A.et al. Endemic pemphigus foliaceus (fogo salvegem): current and historic epidemiologic studies. J Invest Dermatol. 92:1989;4-12.
17. Robledo M.A., Prada S., Jamarillo D., Leon W. South American pemphigus foliaceus (SPF): study of an epidemic in "El Bare and Nichi", Colombia (1982-1986). Br J Dermatol. 118:1988;737-744.
18. Moraes M.E., Fernandez-Vina M.V., Stasny P.et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in the three different Brazilian populations. Tissue Antigens. 49:1997;35-40.
19. Brenner S., Bialy-Golan A., Ruocco V. Drug-induced pemphigus in diagnostic immunohistochemistry of the skin. In: Kanitakis J., Vassileva S., Woodley D., eds. London: Chapman & Hall, 1998: 8: 84-94.
20. Anhalt G.J., Kim S-C., Stanley J.R.et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 323:1990;1729-1735.
21. Anhalt G.J. Paraneoplastic pemphigus. Adv Dermatol. 12:1997;77-96.
22. Amagai M., Nishikawa T., Nousari H.C.et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 102:1998;775-782.
23. Nousari H.C., Deterding R., Wojtczack H.A.et al. The mechanism of respratory failure in paraneoplastic pemphigus. N Engl J Med. 340:1999;1406-1410.
24. Nousari H.C., Brodsky R.A., Jones R.J.et al. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol. 1999;. in press.
25. Black M.M. New observations on pemphigoid herpes gestationis. Dermatology. 189(suppl):1994;50-51.
26. Zillikens D., Mascaro J.M., Rose P.A.et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP 180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol. 109:1997;679-683.
27. Muller S., Klaus-Kovtun V., Stanley J.R. A 230 kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol. 92:1989;33-38.
28. Guidice G.J., Emery D.J., Diaz L.A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol. 99:1992;243-250.
29. Liu Z., Guidice G.J., Zhou X.et al. A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest. 100:1997;1256-1263.
30. Liu Z., Giudice G.J., Swartz S.J.et al. The role of complement in experimental bullous pemphigoid. J Clin Invest. 95:1995;1539-1544.
31. Stahle-Backdahl M., Inoue M., Guidice G.J., Parks W. 92-kD gelatinase is produced by eosinophils at the site of blister formation of bullous pemphigoid and autoantigen. J Clin Invest. 93:1994;2022-2030.